CervoMed terminates $20M ATM equity facility with BTIG; no shares sold

CervoMed Inc.

Terminated At-The-Market Sales Agreement with BTIG, effective October 11, 2024.
No shares were ever issued under the $20M facility; no termination penalties apply.
Company notified BTIG on October 1, 2024 of the termination.
Originally entered into July 22, 2022; no proceeds or dilution occurred.

item 1.02

CervoMed Inc. filing history →

Source: SEC EDGAR

accession 0001437749-24-030613

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.